These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15289283)

  • 1. Novel diacylglycerol kinase inhibitor selectively suppressed an U46619-induced enhancement of mouse portal vein contraction under high glucose conditions.
    Nobe K; Miyatake M; Nobe H; Sakai Y; Takashima J; Momose K
    Br J Pharmacol; 2004 Sep; 143(1):166-78. PubMed ID: 15289283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement effect under high-glucose conditions on U46619-induced spontaneous phasic contraction in mouse portal vein.
    Nobe K; Sakai Y; Nobe H; Takashima J; Paul RJ; Momose K
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1129-42. PubMed ID: 12604690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose-dependent enhancement of spontaneous phasic contraction is suppressed in diabetic mouse portal vein: association with diacylglycerol-protein kinase C pathway.
    Nobe K; Suzuki H; Sakai Y; Nobe H; Paul RJ; Momose K
    J Pharmacol Exp Ther; 2004 Jun; 309(3):1263-72. PubMed ID: 14988417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-glucose enhances a thromboxane A2-induced aortic contraction mediated by an alteration of phosphatidylinositol turnover.
    Nobe K; Suzuki H; Nobe H; Sakai Y; Momose K
    J Pharmacol Sci; 2003 Jul; 92(3):267-82. PubMed ID: 12890893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-glucose-altered endothelial cell function involves both disruption of cell-to-cell connection and enhancement of force development.
    Nobe K; Miyatake M; Sone T; Honda K
    J Pharmacol Exp Ther; 2006 Aug; 318(2):530-9. PubMed ID: 16699065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signalling pathway of U46619-induced vascular smooth muscle contraction in mouse coronary artery.
    Jiang RS; Zhang L; Yang H; Zhou MY; Deng CY; Wu W
    Clin Exp Pharmacol Physiol; 2021 Jul; 48(7):996-1006. PubMed ID: 33792963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the involvement of protein kinase C in agonist-induced contractions in mouse aorta and corpus cavernosum.
    Jin L; Teixeira CE; Webb RC; Leite R
    Eur J Pharmacol; 2008 Aug; 590(1-3):363-8. PubMed ID: 18614166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective and potent inhibitory effect of docosahexaenoic acid (DHA) on U46619-induced contraction in rat aorta.
    Sato K; Chino D; Kobayashi T; Obara K; Miyauchi S; Tanaka Y
    J Smooth Muscle Res; 2013; 49():63-77. PubMed ID: 24304639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel angiotensin II AT(1) receptor antagonist irbesartan prevents thromboxane A(2)-induced vasoconstriction in canine coronary arteries and human platelet aggregation.
    Li P; Fukuhara M; Diz DI; Ferrario CM; Brosnihan KB
    J Pharmacol Exp Ther; 2000 Jan; 292(1):238-46. PubMed ID: 10604953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Difference in signal transduction mechanisms involved in 5-hydroxytryptamine- and U46619-induced vasoconstrictions.
    Tasaki K; Hori M; Ozaki H; Karaki H; Wakabayashi I
    J Smooth Muscle Res; 2003 Oct; 39(5):107-17. PubMed ID: 14695024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diacylglycerol regulates acute hypoxic pulmonary vasoconstriction via TRPC6.
    Fuchs B; Rupp M; Ghofrani HA; Schermuly RT; Seeger W; Grimminger F; Gudermann T; Dietrich A; Weissmann N
    Respir Res; 2011 Feb; 12(1):20. PubMed ID: 21294865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of U46619 on contractions to 5-HT, sumatriptan and methysergide in canine coronary artery and saphenous vein in vitro.
    Kemp BK; Cocks TM
    Br J Pharmacol; 1995 Oct; 116(4):2183-90. PubMed ID: 8564247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of contractile responses to 5-hydroxytryptamine and sumatriptan in human isolated coronary artery: synergy with the thromboxane A2-receptor agonist, U46619.
    Cocks TM; Kemp BK; Pruneau D; Angus JA
    Br J Pharmacol; 1993 Sep; 110(1):360-8. PubMed ID: 8220898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible role of atypical protein kinase C activated by arachidonic acid in Ca2+ sensitization of rabbit smooth muscle.
    Gailly P; Gong MC; Somlyo AV; Somlyo AP
    J Physiol; 1997 Apr; 500 ( Pt 1)(Pt 1):95-109. PubMed ID: 9097936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glibenclamide inhibits thromboxane-mediated vasoconstriction by thromboxane receptor blockade.
    Pfister SL; Pratt PE; Kurian J; Campbell WB
    Vascul Pharmacol; 2004 Jan; 40(6):285-92. PubMed ID: 15063832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular calcium and myosin light chain phosphorylation during U46619-activated vascular contraction.
    Jiang MJ; Chan CF; Chang YL
    Life Sci; 1994; 54(25):2005-13. PubMed ID: 7515455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of voltage-dependent and Ca(2+)-activated K(+) channels on the regulation of isometric force in porcine coronary artery.
    Shimizu S; Yokoshiki H; Sperelakis N; Paul RJ
    J Vasc Res; 2000; 37(1):16-25. PubMed ID: 10720882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxide generation by p47phox-Src activation of Nox2 has a key role in protein kinase C-induced arterial smooth muscle contraction.
    Gupte SA; Kaminski PM; George S; Kouznestova L; Olson SC; Mathew R; Hintze TH; Wolin MS
    Am J Physiol Heart Circ Physiol; 2009 Apr; 296(4):H1048-57. PubMed ID: 19168729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific attenuation of the pressure-induced contraction of rat cerebral artery by herbimycin A.
    Masumoto N; Nakayama K; Oyabe A; Uchino M; Ishii K; Obara K; Tanabe Y
    Eur J Pharmacol; 1997 Jul; 330(1):55-63. PubMed ID: 9228414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pore-forming subunit of the K(ATP) channel is an important molecular target for LPS-induced vascular hyporeactivity in vitro.
    O'Brien AJ; Thakur G; Buckley JF; Singer M; Clapp LH
    Br J Pharmacol; 2005 Feb; 144(3):367-75. PubMed ID: 15655519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.